Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors

Shih, 1999, Annu. Rev. Neurosci., 22, 197, 10.1146/annurev.neuro.22.1.197 Edmondson, 2009, Biochemistry, 48, 4220, 10.1021/bi900413g Fernández, 2007, Pharmacotherapy, 27, 147S, 10.1592/phco.27.12part2.174S Youdin, 2006, Brit. J. Pharmacol., 147, S287, 10.1038/sj.bjp.0706464 Finberg, 2014, Pharmacol. Ther., 143, 133, 10.1016/j.pharmthera.2014.02.010 Deeks, 2015, Drugs, 75, 705, 10.1007/s40265-015-0389-7 Rieder, 2004, Neurotoxicology, 25, 271, 10.1016/S0161-813X(03)00106-2 Ebadi, 2006, Curr. Drug Targets, 7, 1513, 10.2174/1389450110607011513 Naoi, 2013, Expert Rev. Neurother., 120, 671, 10.1586/ern.13.60 Carradori, 2015, J. Med. Chem., 58, 6717, 10.1021/jm501690r Distinto, 2016, Eur. J. Med. Chem., 108, 542, 10.1016/j.ejmech.2015.12.026 Hammuda, 2016, Eur. J. Med. Chem., 114, 162, 10.1016/j.ejmech.2016.02.038 Fioravanti, 2013, Bioorg. Med. Chem. Lett., 23, 5128, 10.1016/j.bmcl.2013.07.035 Meiring, 2013, Bioorg. Med. Chem. Lett., 23, 5498, 10.1016/j.bmcl.2013.08.071 Chirkova, 2015, Bioorg. Med. Chem. Lett., 25, 1206, 10.1016/j.bmcl.2015.01.061 Tzvetkov, 2014, J. Med. Chem., 57, 6679, 10.1021/jm500729a Nam, 2017, ACS Chem. Neurosci. Maccioni, 2011, J. Med. Chem., 54, 6394, 10.1021/jm2002876 Reis, 2016, J. Med. Chem., 59, 5879, 10.1021/acs.jmedchem.6b00527 Mertens, 2014, Bioorg. Med. Chem., 22, 1916, 10.1016/j.bmc.2014.01.046 Pisani, 2015, Eur. J. Med. Chem., 89, 98, 10.1016/j.ejmech.2014.10.029 Joubert, 2017, Eur. J. Med. Chem., 125, 853, 10.1016/j.ejmech.2016.09.041 Chimenti, 2009, J. Med. Chem., 52, 1935, 10.1021/jm801496u Secci, 2011, Eur. J. Med. Chem., 46, 4846, 10.1016/j.ejmech.2011.07.017 Matos, 2009, Bioorg. Med. Chem. Lett., 19, 5053, 10.1016/j.bmcl.2009.07.039 Matos, 2010, Bioorg. Med. Chem. Lett., 20, 5157, 10.1016/j.bmcl.2010.07.013 Matos, 2011, J. Med. Chem., 54, 7127, 10.1021/jm200716y Matos, 2014, ChemMedChem, 9, 1488, 10.1002/cmdc.201300533 Matos, 2015, Bioorg. Med. Chem. Lett., 25, 642, 10.1016/j.bmcl.2014.12.001 Delogu, 2011, Eur. J. Med. Chem., 46, 1147, 10.1016/j.ejmech.2011.01.033 Lan, 2015, Med. Chem. Commun., 6, 592, 10.1039/C4MD00437J Evans, 1998, J. Med. Chem., 31, 2235, 10.1021/jm00120a002 Riveiro, 2010, Curr. Med. Chem., 17, 1325, 10.2174/092986710790936284 Wermuth, 2011, Med. Chem. Commun., 2, 935, 10.1039/C1MD00074H Ingham, 1975, Aus. J. Chem., 2499, 10.1071/CH9752499 Lees, 2005, Drugs Aging, 22, 731, 10.2165/00002512-200522090-00002 Copeland, 2005 2014 Binda, 2007, J. Med. Chem., 50, 5848, 10.1021/jm070677y Delogu, 2014, ChemMedChem, 9, 1672 Matos, 2014, Future Med. Chem., 6, 371, 10.4155/fmc.14.9 RCSB Protein Data Bank - RCSB PDB. http://www.rcsb.org/. Liu, 2012, Molecules, 17, 2000, 10.3390/molecules17022000 Edmondson, 2007, J. Neural. Transm., 114, 703, 10.1007/s00702-007-0674-z Mladenovic, 2017, J. Chem. Inf. Model, 57, 787, 10.1021/acs.jcim.6b00608 Matos, 2013, Eur. J. Med. Chem., 63, 151, 10.1016/j.ejmech.2013.02.009 Liu, 1997, J. Neurochem., 69, 581, 10.1046/j.1471-4159.1997.69020581.x M. Cheminformatics, Bratislava, Slovak Republic, http://www.molispiration.com/services/properties-html (Accessed May 2017). Lipinsky, 1997, Adv. Drug Deliv. Rev., 23, 3, 10.1016/S0169-409X(96)00423-1 http://www.cbligand.org/BBB/index.php. Constantinescu, 2007, J. Neural. Transm., S72, 17